iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://www.ncbi.nlm.nih.gov/pubmed/22216036
Sundown syndrome in persons with dementia: an update - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec;8(4):275-87.
doi: 10.4306/pi.2011.8.4.275. Epub 2011 Nov 4.

Sundown syndrome in persons with dementia: an update

Nina Khachiyants  1 , David Trinkle, Sang Joon Son, Kye Y Kim
Affiliations

Sundown syndrome in persons with dementia: an update

Nina Khachiyants et al. Psychiatry Investig. 2011 Dec.

Abstract

"Sundowning" in demented individuals, as distinct clinical phenomena, is still open to debate in terms of clear definition, etiology, operationalized parameters, validity of clinical construct, and interventions. In general, sundown syndrome is characterized by the emergence or increment of neuropsychiatric symptoms such as agitation, confusion, anxiety, and aggressiveness in late afternoon, in the evening, or at night. Sundowning is highly prevalent among individuals with dementia. It is thought to be associated with impaired circadian rhythmicity, environmental and social factors, and impaired cognition. Neurophysiologically, it appears to be mediated by degeneration of the suprachiasmatic nucleus of the hypothalamus and decreased production of melatonin. A variety of treatment options have been found to be helpful to ameliorate the neuropsychiatric symptoms associated with this phenomenon: bright light therapy, melatonin, acetylcholinesterase inhibitors, N-methyl-d-aspartate receptor antagonists, antipsychotics, and behavioral modifications. To decrease the morbidity from this specific condition, improve patient's well being, lessen caregiver burden, and delay institutionalization, further attention needs to be given to development of clinically operational definition of sundown syndrome and investigations on etiology, risk factors, and effective treatment options.

Keywords: Alzheimer's disease; Dementia; Sundowning.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cameron DE. Studies in senile nocturnal delirium. Psychiatr Q. 1941;15:47–53.
    1. Kim P, Louis C, Muralee S, Tampi RR. Sundowning syndrome in the older patient. Clin Geriatr. 2005;13:32–36.
    1. Hess CW. Sleep disorders and dementia. Praxis (Bern 1994) 1997;86:1343–1349. - PubMed
    1. Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A. Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry. 2001;158:704–711. - PubMed
    1. Rindlisbacher P, Hopkins RW. An investigation of the sundowning syndrome. Int J Geriatr Psychiatry. 1992;7:15–23.

LinkOut - more resources